RedHill Biopharma Ltd. (RDHL)

4.96
0.05 1.00
NASDAQ : Health Technology
Prev Close 5.01
Open 5.10
Day Low/High 4.91 / 5.10
52 Wk Low/High 4.30 / 11.25
Volume 23.29K
Avg Volume 76.90K
Exchange NASDAQ
Shares Outstanding 21.27M
Market Cap 103.77M
EPS -2.60
P/E Ratio 19.27
Div & Yield N.A. (N.A)

Latest News

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

Celgene Down After Pulling Plug on Crohn's Disease Drug Study -- Biotech Movers

The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.

TheStreet Quant Rating: D- (Sell)